Details

Autor(en) / Beteiligte

• McLEAN, E.
• PEBODY, R. G.
• CAMPBELL, C.
• CHAMBERLAND, M.
• HAWKINS, C.
• NGUYEN-VAN-TAM, J. S.
• OLIVER, I.
• SMITH, G. E.
• IHEKWEAZU, C.
• BRACEBRIDGE, S.
• MAGUIRE, H.
• HARRIS, R.
• KAFATOS, G.
• WHITE, P. J.
• WYNNE-EVANS, E.
• GREEN, J.
• MYERS, R.
• UNDERWOOD, A.
• DALLMAN, T.
• WREGHITT, T.
• ZAMBON, M.
• ELLIS, J.
• PHIN, N.
• SMYTH, B.
• McMENAMIN, J.
• WATSON, J. M.

Titel

Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases

Ist Teil von

• Epidemiology and infection, 2010-11, Vol.138 (11), p.1531-1541

Ort / Verlag

Cambridge, UK: Cambridge University Press

Erscheinungsjahr

2010

Quelle

MEDLINE

Beschreibungen/Notizen

• The UK was one of few European countries to document a substantial wave of pandemic (H1N1) 2009 influenza in summer 2009. The First Few Hundred (FF100) project ran from April–June 2009 gathering information on early laboratory-confirmed cases across the UK. In total, 392 confirmed cases were followed up. Children were predominantly affected (median age 15 years, IQR 10–27). Symptoms were mild and similar to seasonal influenza, with the exception of diarrhoea, which was reported by 27%. Eleven per cent of all cases had an underlying medical condition, similar to the general population. The majority (92%) were treated with antiviral drugs with 12% reporting adverse effects, mainly nausea and other gastrointestinal complaints. Duration of illness was significantly shorter when antivirals were given within 48 h of onset (median 5 vs. 9 days, P=0·01). No patients died, although 14 were hospitalized, of whom three required mechanical ventilation. The FF100 identified key clinical and epidemiological characteristics of infection with this novel virus in near real-time.